Journal Information
Vol. 11. Issue 4.
Pages 345-349 (July - August 2005)
Share
Share
Download PDF
More article options
Vol. 11. Issue 4.
Pages 345-349 (July - August 2005)
Editorial\Editorial
Open Access
Fibrose quística – Vinte anos após a localização do locus do gene
Visits
4365
Celeste Barreto1
1 Centro Especializado de Fibrose Quística, Hospital de Santa Maria, Lisboa.
This item has received

Under a Creative Commons license
Article information
Full text is only aviable in PDF
Bibliografia
[1.]
Tsui.
Cystic Fibrosis locus defined by a genetically linked polymorphic DNA marker.
Science, 230 (1985), pp. 1054-1057
[2.]
B. Pamela, et al.
State of the Art, Cystic Fibrosis.
Am J Respir Crit Care Med, 154 (1996), pp. 1229-1256
[3.]
J.R. Riordan, J.M. Rommens, B.-S. Kerem, et al.
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
Science, 245 (1989), pp. 1066-1073
[4.]
R.C. Boucher.
New concepts of the pathogenesis of cystic fibrosis lung disease.
Eur Respir J, 23 (2004), pp. 146-158
[5.]
A. Brennan, D. Geddes.
Bringing New Treatments to the Bedside in Cystic Fibrosis.
Pediatr Pulmonol;, 37 (2004), pp. 87-98
[6.]
M.D. Amaral.
Processing of CFTR: Traversing the Cellular Maze-How Much CFTR Needs to Go Through to Avoid Cystic Fibrosis?.
Pediatr Pulmonol;, 39 (2005), pp. 479-491
[7.]
N. Hoiby, G. Doring, P.O. Shiotz.
The role of immune compexes in the pathogenesis of bacterial infection.
Annu Rev Microbiol, 40 (1986), pp. 29-53
[8.]
The Cystic Fibrosis Genetic Analysis Consortium - The CFTR mutation database.
[9.]
P. Pacheco.
Contributed with the Detection rate of CF-causing CFTR mutations in Portugal.
The Molecular Genetic Epidemiology of Cystic Fibrosis, (2004),
[10.]
Barreto C, Pereira L Como interpertar as Provas de Suor com valores borderline no diagnóstico de Fibrose Quística. Acta Pediatr Port 35 (3): 261-266.
[11.]
Stephanie Hirtz, Tanja Gonska, Hans H. Seydewitz, Jorg Thomas, Peter Greiner, Joachim Kuehr, Matthias Brandis, Irmgard Eichler, Herculano Rocha, Ana Isabel Lopes, Celeste Barreto, Anabela Ramalho, Margarida Amaral, Karl Kunzelmann, Marcus Mall.
CFTR Cl- Cannel Function in Native Human Colon Correlates With the Genotype and Phenotype in Cystic Fibrosis.
Gastroenterology, 127 (2004), pp. 1085-1095
[12.]
M.D. Amaral, et al.
Cystic Fibrosis patients with the 3272-26A’!A spicing mutation have milder disease than F508del homozygotes: a large European study.
J Med Genet, 38 (2001), pp. 777-783
[14.]
L. Pereira, T. Bandeira, I. Amaral, C. Barreto.
Aumento da esperança média de vida nos doentes com Fibrose Quística: experiência do Centro de Fibrose Quística da Unidade de Pneumologia do Serviço de Pediatria do Hospital de Santa Maria.
Rev Port Pneumol, IV (1998), pp. 599-609
[15.]
R. Mahadeva, et al.
Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.
BMJ, 316 (1998), pp. 1771-1775
[16.]
E. Kerem, S. Conway, S. Elborn.
Heijerman.
Standards of care for patients with cystic fibrosis: a European consensus. Journal of Cystic Fibrosis, 4 (2005), pp. 7-26
Copyright © 2005. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?